Better Choice Company to Present at the 2024 ThinkEquity Conference and Provides Detail on Sales in China and the Acquisition of SRx Health
Better Choice Company (NYSE: BTTR), a pet health and wellness company, announced its participation in the 2024 ThinkEquity Conference on October 30th at the Mandarin Oriental Hotel in New York City. The company will provide updates on its international sales performance and the ongoing acquisition of SRx Health.
Key highlights include:
- Continued sales growth in China, with a 37% sequential increase in Q2 2024 compared to Q1 2024
- International sales account for approximately 28% of Better Choice's total revenue
- China remains a key market for expansion, with the Halo brand gaining recognition and winning industry awards
- The SRx Health acquisition is progressing as planned
Better Choice Company (NYSE: BTTR), un'azienda dedicata alla salute e al benessere degli animali domestici, ha annunciato la sua partecipazione alla 2024 ThinkEquity Conference che si terrà il 30 ottobre presso il Mandarin Oriental Hotel di New York. L'azienda fornirà aggiornamenti sulle sue performance di vendita internazionali e sull'acquisizione di SRx Health in corso.
I punti salienti includono:
- Crescita continua delle vendite in Cina, con un incremento sequenziale del 37% nel secondo trimestre del 2024 rispetto al primo trimestre del 2024
- Le vendite internazionali rappresentano circa il 28% del fatturato totale di Better Choice
- La Cina rimane un mercato chiave per l'espansione, con il marchio Halo che sta guadagnando riconoscimento e vincendo premi del settore
- L'acquisizione di SRx Health sta procedendo come previsto
Better Choice Company (NYSE: BTTR), una empresa de salud y bienestar para mascotas, anunció su participación en la 2024 ThinkEquity Conference el 30 de octubre en el Mandarin Oriental Hotel de Nueva York. La compañía proporcionará actualizaciones sobre su desempeño en ventas internacionales y la adquisición de SRx Health que está en curso.
Los aspectos destacados incluyen:
- Crecimiento continuo de ventas en China, con un incremento secuencial del 37% en el segundo trimestre de 2024 en comparación con el primer trimestre de 2024
- Las ventas internacionales representan aproximadamente el 28% de los ingresos totales de Better Choice
- China sigue siendo un mercado clave para la expansión, con la marca Halo ganando reconocimiento y premios en la industria
- La adquisición de SRx Health está avanzando según lo planeado
Better Choice Company (NYSE: BTTR)는 반려동물 건강 및 웰니스 기업으로, 10월 30일 뉴욕 만다린 오리엔탈 호텔에서 열리는 2024 ThinkEquity Conference에 참여할 예정이라고 발표했습니다. 이 회사는 국제 판매 성과 및 진행 중인 SRx Health 인수에 대한 업데이트를 제공할 것입니다.
주요 사항은 다음과 같습니다:
- 2024년 1분기 대비 2024년 2분기 중국에서 37%의 순차적 증가를 기록하며 지속적인 매출 성장을 보여주고 있습니다.
- 국제 매출은 Better Choice의 총 수익의 약 28%를 차지합니다.
- 중국은 Halo 브랜드가 인정받고 산업 상을 수상하며 확장을 위한 주요 시장으로 남아 있습니다.
- SRx Health 인수는 계획대로 진행되고 있습니다.
Better Choice Company (NYSE: BTTR), une entreprise de santé et de bien-être pour animaux de compagnie, a annoncé sa participation à la 2024 ThinkEquity Conference qui se tiendra le 30 octobre au Mandarin Oriental Hotel à New York. L'entreprise fournira des mises à jour sur sa performance commerciale internationale et l'acquisition de SRx Health en cours.
Les points clés incluent:
- Une croissance continue des ventes en Chine, avec une augmentation séquentielle de 37% au T2 2024 par rapport au T1 2024
- Les ventes internationales représentent environ 28% du chiffre d'affaires total de Better Choice
- La Chine reste un marché clé pour l'expansion, la marque Halo gagnant en reconnaissance et remportant des prix dans l'industrie
- L'acquisition de SRx Health progresse comme prévu
Better Choice Company (NYSE: BTTR), ein Unternehmen für die Gesundheit und das Wohlbefinden von Haustieren, gab seine Teilnahme an der 2024 ThinkEquity Conference am 30. Oktober im Mandarin Oriental Hotel in New York City bekannt. Das Unternehmen wird Updates zu seiner internationalen Verkaufsleistung und der laufenden Übernahme von SRx Health bereitstellen.
Wichtige Highlights sind:
- Fortgesetztes Verkaufswachstum in China mit einem 37% sequenziellen Anstieg im 2. Quartal 2024 im Vergleich zum 1. Quartal 2024
- Internationale Verkäufe machen etwa 28% des Gesamterlöses von Better Choice aus
- China bleibt ein wichtiger Markt für die Expansion, wobei die Marke Halo an Anerkennung gewinnt und Branchenpreise gewinnt
- Die SRx Health Übernahme verläuft planmäßig
- 37% sequential sales growth in China for Q2 2024
- International sales account for 28% of total revenue
- Halo brand gaining recognition and winning awards in China
- SRx Health acquisition progressing on track
- None.
Sustained Sales Momentum in China in Q3 Following
Acquisition of SRx Health Remains On-Track
TAMPA, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it will present at the ThinkEquity Conference on October 30th, 2024 at the Mandarin Oriental Hotel in New York City. During the conference, management will provide updates on its international sales performance and the ongoing acquisition of SRx Health.
Key Highlights will Include:
- China Sales Growth: The Company continues to experience sales growth internationally, with sales from China increasing
37% sequentially for the second quarter of 2024 as compared to the first quarter of 2024. International sales account for approximately28% of Better Choice total revenue, and China remains a key market for expansion, especially as the Halo brand continues to gain recognition and win industry awards. - SRx Health Acquisition: The acquisition of SRx Health remains on-track, with further updates to be provided during the Company’s presentation at the ThinkEquity Conference.
Management will be available for 1x1 meetings throughout the conference. If you are interested, please contact your ThinkEquity representative or email KCSA directly at BetterChoice@KCSA.com.
About Better Choice Company Inc.
Better Choice Company Inc. is a rapidly growing pet health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier, and longer lives. We take an alternative, nutrition-based approach to pet health relative to conventional dog and cat food offerings and position our portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. We have a demonstrated, multi-decade track record of success selling trusted pet health and wellness products and leverage our established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. We sell the majority of our dog food, cat food and treats under the Halo brand, which is focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats. For more information, please visit
https://www.betterchoicecompany.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Company Contact:
Better Choice Company, Inc.
Kent Cunningham, CEO
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com
FAQ
What was Better Choice Company's (BTTR) sales growth in China for Q2 2024?
What percentage of Better Choice Company's (BTTR) total revenue comes from international sales?
Is Better Choice Company (BTTR) still proceeding with the acquisition of SRx Health?